Overview

Comparison of Nebulized Budesonide and Intranasal Budesonide Spray in Children With Adenotonsillar Hypertrophy

Status:
Not yet recruiting

Trial end date:
2024-09-01

Target enrollment:

Participant gender:

Summary

Budesonide is one of the most common drugs uesd in children with adenotonsillar hypertrophy. This study aimed to evaluate the efficacy of a short course of budesonide inhalation suspension via transnasal nebulization in children with adenotonsillar hypertrophy. The second aim was to compare budesonide inhalation suspension with budesonide aqueous nasal spray in adenotonsillar hypertrophy treatment.

Phase:

Phase 3

Details

Lead Sponsor:

Second Xiangya Hospital of Central South University

Treatments:

Budesonide